Research Analysts Set Expectations for MGRM FY2028 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Research analysts at Roth Capital increased their FY2028 EPS estimates for Monogram Orthopaedics in a report released on Thursday, March 13th. Roth Capital analyst J. Wittes now expects that the company will post earnings of $0.09 per share for the year, up from their previous estimate of $0.06. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ FY2029 earnings at $0.41 EPS.

Monogram Orthopaedics (NASDAQ:MGRM) last announced its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03.

Separately, Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 price target on the stock.

Monogram Orthopaedics Price Performance

Shares of Monogram Orthopaedics stock opened at $2.33 on Friday. The company has a 50-day moving average of $2.54 and a 200 day moving average of $2.49. Monogram Orthopaedics has a 1 year low of $1.53 and a 1 year high of $4.90. The firm has a market cap of $79.95 million, a price-to-earnings ratio of -4.96 and a beta of 1.66.

Institutional Investors Weigh In On Monogram Orthopaedics

Institutional investors have recently modified their holdings of the stock. Jane Street Group LLC purchased a new position in shares of Monogram Orthopaedics in the 4th quarter valued at $25,000. Northern Trust Corp raised its holdings in shares of Monogram Orthopaedics by 110.6% during the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock valued at $109,000 after acquiring an additional 24,088 shares during the last quarter. Wells Fargo & Company MN increased its holdings in shares of Monogram Orthopaedics by 286.6% in the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after purchasing an additional 8,597 shares during the last quarter. Geode Capital Management LLC grew its position in Monogram Orthopaedics by 7.7% in the fourth quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock worth $537,000 after acquiring an additional 16,234 shares during the period. Finally, Orion Portfolio Solutions LLC purchased a new position in Monogram Orthopaedics in the fourth quarter worth approximately $31,000. 0.45% of the stock is owned by institutional investors.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.